Skip to content
Menu

BriaCell Therapeutics Corp. BCT.TO

Full chart Compare
Set alert

Price alert · BCT.TO

All alert types
4.89 CAD -0.01 (-0.20%)

As ofNov 13, 2026, 3:25 PM EST

4.76 Day range 4.89
3.68 52-week range 18.00
YTD
-50.10%
1 year
-64.44%
Market cap
42.70M
EPS (ttm)
-9.66
Shares out
44.20M
Forward P/E
-1.41
YTD return
-50.10%
1-year return
-64.44%
Volume
1.85K
Avg volume
7.30K
Open
4.86
Previous close
4.90
Day's range
4.76 – 4.89
52-week range
3.68 – 18.00
Beta
1.82

5D +0.81 (+17.61%)

55.50FriMonWed5.41

Key statistics

Enterprise value
15.11M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-10.83M
Total cash
862.09K
Total debt
0
Return on equity
0.00%
Short % of float
0.03%
50-day average
1.10
200-day average
1.74

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada
Website
briacell.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on BCT.TO — it syncs with the Stock Master app.

Insider holders

BCT.TO insider holders
InsiderRelationLatest transactionDateShares held
Lustig (Marc)10% Security Holder of IssuerAcquisition or disposition in the public marketFeb 16, 20220

Institution ownership

BCT.TO institution ownership
Holder% heldSharesValueReported
Lynwood Capital Management Inc.3.61%1,597,7501.21MMar 30, 2024
Vontobel Holding Limited0.18%80,00060.80KSep 29, 2024
HRT Financial LP0.17%74,28656.46KSep 29, 2024
Onyx Bridge Wealth Group, LLC0.11%50,00038.00KSep 29, 2024
Group One Trading, L.P.0.09%37,88528.79KSep 29, 2024
Summit Trail Advisors, LLC0.08%35,00026.60KSep 29, 2024

Fund ownership

BCT.TO fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.02%7,2295.49KOct 30, 2024